Is it a Good Decision to Add Regeneron Pharmaceuticals (REGN) to Your Portfolio?
Investment management company RGA Investment Advisors recently released its third-quarter 2022 investor letter. A copy of the same can be downloaded here.
Posts Tagged ‘NASDAQ:REGN’
10 Best Pharmaceutical Stocks to Buy According to Steven Boyd’s Armistice Capital
In this article, we will take a look at some of the notable pharma stocks to buy according to Steven Boyd's Armistice Capital.
Top 5 Stock Picks of John Hempton’s Bronte Capital
In this article, we discuss the top 5 stock picks of John Hempton's Bronte Capital.
Top 5 Trending Stocks on Friday
Shares of Zscaler, Inc. (NASDAQ:ZS) jumped nearly 15 percent in pre-market trading Friday after delivering impressive financial results for its fiscal fourth quarter.
25 Biggest Pharmaceutical Companies in the World A Year Ago
In this article we listed the 25 biggest pharmaceutical companies in the world a year ago and then compared their market caps today.
20 Most Expensive Stocks In the US
Regardless of whether you're a day trader or a long term investor, the 20 most expensive stocks in the US will cause a double-take! No matter what one's situation is, or what...
10 Healthcare Stocks to Watch Amid Senate’s Healthcare Bill
In this article, we will be taking a look at 10 healthcare stocks to watch amid Senate's healthcare bill.
Top 5 Gainers on Wednesday
Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) rose over six percent after the opening bell this morning.
10 Most Profitable Biotech Companies in the World
In this article, we discuss the 10 most profitable biotech companies in the world.
5 Biotech Stocks to Buy According to Billionaire David E. Shaw
In this piece, we will take a look at five biotechnology stocks to buy according to billionaire David E. Shaw.
5 Biotech Stocks to Sell Now According to Cathie Wood
In this article, we discuss 5 biotech stocks to sell now according to Cathie Wood.
10 Best Pharmaceutical Stocks to Buy in 2022
In this article, we discuss the 10 best pharmaceutical stocks to buy in 2022.
How Did Hedge Funds’ Regeneron Pharmaceuticals Inc (REGN) Bets Fare?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy...
5 Best Genomics Stocks to Buy Now
In this article, we will discuss the 5 best genomics stocks to buy now.
5 Best Jim Cramer Stocks to Watch in December
In this article, we discuss the 5 best stocks to watch in December according to Jim Cramer.
Is Regeneron Pharmaceuticals Inc (REGN) A Good Stock To Buy?
In this article we will check out the progression of hedge fund sentiment towards Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and determine whether it is a good investment right...
Why These 5 Stocks Are Trending on Monday
In this article we take a look at five stocks that are trending on Monday.
Was The Smart Money Right About Regeneron Pharmaceuticals Inc (REGN)?
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually don't make them change...
10 Best COVID Stocks To Buy Now
In this article, we discuss the 10 Best COVID Stocks To Buy Now.
10 Best Cancer Stocks To Buy Now
In this article, we discuss the 10 best cancer stocks to buy now.
10 Healthcare Stocks to Buy According to Billionaire Noam Gottesman’s GLG Partners
In this article, we will be taking a look at the 10 healthcare stocks to buy according to billionaire Noam Gottesman's GLG Partners.
Hedge Funds Are Coming Back To Regeneron Pharmaceuticals Inc (REGN)
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of...
Why These 5 Stocks Are on the Move on Friday
In this article we take a look at five stocks that are moving on Friday.
10 Best Healthcare Stocks to Buy According to Matthew Halbower’s Pentwater Capital Management
In this article, we discuss the 10 best healthcare stocks to buy according to Matthew Halbower's Pentwater Capital Management.
Is Regeneron Pharmaceuticals (REGN) A Worthy Investment?
Oakmark Funds, an investment management firm, published its “Oakmark Select Fund” second quarter 2021 investor letter – a copy of which can be seen here. A return of 7...
Bronte Capital on Regeneron (REGN): “A Winner in Mouse Genetics”
Bronte Capital, an investment management firm, published its “Amalthea Fund” second quarter 2021 investor letter – a copy of which can be downloaded here.
10 Stocks that Beat Earnings Estimates
In this article we will take a look at the 10 stocks that beat the earnings estimates.
15 Most Valuable Biotech Companies in the World
In this article we will take a look at the 15 most valuable biotech companies in the world.
Is Regeneron Pharmaceuticals Inc (REGN) A Good Stock To Buy?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
5 Best Pharmaceutical Stocks to Buy According to Cathie Wood
In this article we discuss the 5 best pharmaceutical stocks to buy according to Cathie Wood.
Polen Focus Growth Fund Disposed its Regeneron Pharmaceuticals (REGN) Position, Here’s Why
Polen Capital, an investment management firm, published its “Polen Focus Growth” first quarter 2021 investor letter – a copy of which can be downloaded here.
10 Best Pharma Stocks to Buy Now
In this article we will take a look at the 10 best pharma stocks to buy now.
Is REGN Stock A Buy or Sell?
In this article we will analyze whether Regeneron Pharmaceuticals Inc (NASDAQ:REGN) is a good investment right now by following the lead of some of the best investors in the world...
Is REGN A Good Stock To Buy Now?
At Insider Monkey, we pore over the filings of nearly 817 top investment firms every quarter, a process we have now completed for the latest reporting period.
Why Regeneron Pharmaceuticals (REGN) Stock is a Compelling Investment Case
Polen Capital Management recently released its Q3 2020 Investor Letter, a copy of which you can download here.
Were Hedge Funds Right About Embracing Regeneron Pharmaceuticals Inc (REGN)?
In this article we will check out the progression of hedge fund sentiment towards Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and determine whether it is a good investment right...
Hedge Funds Never Been More Bullish On Regeneron Pharmaceuticals Inc (REGN)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Were Hedge Funds Right About Piling Into Regeneron Pharmaceuticals Inc (REGN)?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Trumpdesivir: Operation Warp Speed, “Engage.”
The COVID-19 vaccine race officially goes into high gear with the announcement of USA’s plan to test the 6-odd top vaccine candidates across upwards of 150,000 volunteers (...
Hedge Funds Aren’t Done Buying Regeneron Pharmaceuticals Inc (REGN)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Should You Be Tempted To ‘Sell’ Regeneron Pharmaceuticals (REGN) Stock
Distillate Capital recently released its Q1 2020 Investor Letter, a copy of which you can download below. The Distillate Capital’s U.S. Fundamental Stability & Value (U.S.
Stocks Amid COVID-19 Outbreak: Winners So Far in the Health Industry
At its worst on March 23rd, Dow Jones and the S&P declined by around 37% and 34%.
Polen Capital is Bullish on Regeneron Pharmaceuticals (REGN) and MSCI (MSCI)
Polen Capital Management, LLC, an independently-owned global investment manager, recently published its first-quarter focus growth commentary – a copy of which can be downloaded...
Hedge Fund and Insider Trading News: Anthony Scaramucci, Pierre Andurand, Howard Marks, East Lodge Capital, Regeneron Pharmaceuticals Inc (REGN), Siebert Financial Corp. (SIEB), and More
Hedge fund manager Ali Lumsden gained 73% the last time the mortgage-bond market went into meltdown. This time around, the veteran investor is on the wrong side of the crisis.
Hedge Fund and Insider Trading News: John Griffin, Jim Simons, Seth Klarman, Daniel Kamensky, Engaged Capital, JPMorgan Chase & Co. (JPM), Columbia Sportswear Company (COLM), and More
For Jim Simons, history is repeating itself, at least when it comes to meltdowns in the quant fund world.
Hedge Funds Have Never Been More Bullish On Regeneron Pharmaceuticals Inc (REGN)
Coronavirus is probably the #1 concern in investors' minds right now. It should be.
2019 Review: Most Favored Hedge Fund Stocks vs. Regeneron Pharmaceuticals Inc (REGN)
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals.
Did Hedge Funds Drop The Ball On Regeneron Pharmaceuticals Inc (REGN) ?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Hedge Funds Have Never Been This Bullish On Regeneron Pharmaceuticals Inc (REGN)
Hedge funds run by legendary names like George Soros and David Tepper make billions of dollars a year for themselves and their super-rich accredited investors (you’ve got to...
Here’s What Hedge Funds Think About Regeneron Pharmaceuticals Inc (REGN)
Reputable billionaire investors such as Jim Simons, Cliff Asness and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in...
